Los Angeles, California
CNS clinical trials in Los Angeles, CA
77 CNS studies are recruiting participants at sites in Los Angeles as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Los Angeles at a glance
- 77 studies are recruiting at a site in Los Angeles.
- By phase: Early Phase 1 (1), Phase 1/2 (7), Phase 2 (14), Phase 2/3 (1), Phase 3 (18), Phase 4 (4), No phase (22), Observational (10). Studies of devices and behavioral approaches have no phase.
- By sponsor: university, hospital or other (40), industry (37).
- By research area: Depression (28), Parkinson's Disease (15), Schizophrenia (10), Epilepsy (9), Migraine (6), ADHD (4), Bipolar Disorder (3), Multiple Sclerosis (2).
- Most recent update to one of these records: November 13, 2026.
Depression studies recruiting in Los Angeles
Basic details from each study's public record (the 30 most recently updated of 77). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Phase 3
- Ages 18 to 85
- All sexes
- Sponsor
- Cybin IRL Limited
- Study sites
- CalNeuro Research Group · Lipov Medical Group
- Registry record
- NCT06793397 · updated
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- LivaNova
- Study site
- Keck Hospital of USC
- Registry record
- NCT03887715 · updated
E-Mindfulness Approaches for Living After Breast Cancer
- Phase 3
- Ages 18 to 50
- All sexes
- Sponsor
- NRG Oncology
- Study sites
- Kaiser Permanente Los Angeles Medical Center · Kaiser Permanente West Los Angeles · Los Angeles General Medical Center
- Registry record
- NCT06748222 · updated
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT06966401 · updated
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
- Phase 2
- Ages 18 to 75
- All sexes
- Sponsor
- Alto Neuroscience
- Registry record
- NCT07553637 · updated
In-patient SCC TMS
- No phase
- Ages 18 to 65
- All sexes
- Sponsor
- University of California, Los Angeles
- Study site
- UCLA TMS Service and Research Service
- Registry record
- NCT05645575 · updated
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- No phase
- Ages 22 to 70
- All sexes
- Sponsor
- Abbott Medical Devices
- Study sites
- UCLA Department of Psychiatry · USC University Hospital
- Registry record
- NCT06423430 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Los Angeles, CA on ClinicalTrials.gov.
Schizophrenia studies recruiting in Los Angeles
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study site
- USC - The Memory and Aging Center (MAC) - Alzheimer Disease Research Center (ADRC)
- Registry record
- NCT06585787 · updated
Developing a Recovery-Oriented Suicide Prevention Program for Young People at Clinical High Risk for Psychosis
- No phase
- Ages 12 to 30
- All sexes
- Sponsor
- University of California, San Diego
- Study site
- University of California, Los Angeles
- Registry record
- NCT07756567 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Los Angeles, CA on ClinicalTrials.gov.
Bipolar disorder studies recruiting in Los Angeles
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- NRC Research Institute
- Registry record
- NCT06951698 · updated
Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in Los Angeles, CA on ClinicalTrials.gov.
ADHD studies recruiting in Los Angeles
The Myelin Disorders Biorepository Project
- Observational
- All ages
- All sexes
- Sponsor
- Children's Hospital of Philadelphia
- Study site
- Children's Hospital of Los Angeles
- Registry record
- NCT03047369 · updated
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Registry record
- NCT07717892 · updated
Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure
- No phase
- Ages 8 to 12
- All sexes
- Sponsor
- University of California, Los Angeles
- Study site
- University of California Los Angeles Semel Institute Division of Child & Adolescent Psychiatry
- Registry record
- NCT06847165 · updated
AWARE: Management of ADHD in Autism Spectrum Disorder
- Phase 4
- Ages 4 to 17
- All sexes
- Sponsor
- Daniel Coury
- Study site
- Children's Hospital Los Angeles
- Registry record
- NCT05916339 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Los Angeles, CA on ClinicalTrials.gov.
Parkinson's disease studies recruiting in Los Angeles
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- UCLA Hematology/Oncology - Santa Monica ( Site 6905)
- Registry record
- NCT06469944 · updated
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Boston Scientific Corporation
- Study site
- Cedars Sinai Medical Center
- Registry record
- NCT02071134 · updated
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- UCLA Department of Medicine - Hematology & Oncology ( Site 0047)
- Registry record
- NCT06841354 · updated
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study sites
- UCLA Jonsson Comprehensive Cancer Center ( Site 0135) · USC Norris Comprehensive Cancer Center ( Site 0205)
- Registry record
- NCT06623422 · updated
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Phase 3
- Ages 50 to 85
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study sites
- Keck School of Medicine of USC · UCLA Neurology Outpatient Clinic
- Registry record
- NCT07174310 · updated
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- Phase 3
- Ages 45 to 75
- All sexes
- Sponsor
- BlueRock Therapeutics
- Study site
- UCLA NeuroTranslational Research Center
- Registry record
- NCT06944522 · updated
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- Phase 2
- Ages 40 to 80
- All sexes
- Sponsor
- Neuron23 Inc.
- Study site
- University of California, Los Angeles
- Registry record
- NCT06680830 · updated
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- Phase 2
- Ages 30 to 80
- All sexes
- Sponsor
- Appello Pharmaceuticals, Inc.
- Study site
- Keck Medicine of USC - USC Healthcare Center 2 (Site #221)
- Registry record
- NCT07432958 · updated
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Phase 2/3
- Ages 40 to 80
- All sexes
- Sponsor
- Biohaven Therapeutics Ltd.
- Registry record
- NCT06976268 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Los Angeles, CA on ClinicalTrials.gov.
Epilepsy studies recruiting in Los Angeles
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Phase 3
- Ages 12 and older
- All sexes
- Sponsor
- Xenon Pharmaceuticals Inc.
- Study site
- Brain Science Research Institute
- Registry record
- NCT05667142 · updated
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Xenon Pharmaceuticals Inc.
- Study site
- University of California Los Angeles (UCLA)
- Registry record
- NCT05716100 · updated
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Neurona Therapeutics
- Study sites
- University of California Los Angeles · University of Southern California Keck Hospital
- Registry record
- NCT05135091 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Los Angeles, CA on ClinicalTrials.gov.
Migraine studies recruiting in Los Angeles
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Phase 4
- Ages 18 to 70
- All sexes
- Sponsor
- Mayo Clinic
- Study sites
- Clinical Research Institute · Keck School of Medicine of USC
- Registry record
- NCT06972056 · updated
Study of EVO756 in Adults With Migraine
- Phase 2
- Ages 18 to 64
- All sexes
- Sponsor
- Evommune, Inc.
- Study site
- CA Medical Clinic for Headache
- Registry record
- NCT07616128 · updated
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Study sites
- Clinical Research Institute · Downtown L.A. Research Center, Inc.
- Registry record
- NCT07645924 · updated
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Study sites
- Clinical Research Institute · Downtown L.A. Research Center, Inc.
- Registry record
- NCT07674654 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Los Angeles, CA on ClinicalTrials.gov.
Ask about studies near Los Angeles
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in California
All California locations
328 studies recruiting across 126 cities.
San Diego
53 studies recruiting.
San Francisco
53 studies recruiting.
Orange
44 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections